Antitumour necrosis factor-α therapy modulates angiopoietin-2 serum levels in non-diabetic ankylosing spondylitis patients-Reference-Cited by-同舟云学术

Antitumour necrosis factor-α therapy modulates angiopoietin-2 serum levels in non-diabetic ankylosing spondylitis patients

Published:2013-03-12 Issue:7 Volume:72 Page:1265-1267
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Genre Fernanda,Miranda-Filloy José A,López-Mejias Raquel,Carnero-López Beatriz,Ochoa Rodrigo,Rueda Javier,González-Juanatey Carlos,Blanco Ricardo,Llorca Javier,González-Gay Miguel A

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference10 articles.

1. Atherosclerosis and endothelial dysfunction in patients with ankylosing spondylitis;Azevedo;Rheumatol Int,2010

2. Investigation of effects of different treatment modalities on structural and functional vessel wall properties in patients with ankylosing spondylitis;Capkin;Joint Bone Spine,2011

3. Ankylosing spondylitis: a risk factor for myocardial infarction?;Peters;Ann Rheum Dis,2010

4. The European ankylosing spondylitis infliximab cohort (EASIC): a European multicentre study of long term outcomes in patients with ankylosing spondylitis treated with infliximab;Heldmann;Clin Exp Rheumatol,2011

5. TNF-α antagonist therapy improves insulin sensitivity in non-diabetic ankylosing spondylitis patients;Miranda-Filloy;Clin Exp Rheumatol,2012

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polymorphisms of HLA-A, -B, -Cw and DRB1 antigens in Moroccan patients with ankylosing spondylitis and a comparison of clinical features with frequencies ofHLA-B*27;Tissue Antigens;2015-01-28

2. Autoantibodies and biomarkers of endothelial cell activation in atherosclerosis;Vasa;2014-03-01

3. The effects of golimumab on subclinical atherosclerosis and arterial stiffness in ankylosing spondylitis--a randomized, placebo-controlled pilot trial;Rheumatology;2014-02-05

4. Serum Levels of Three Angiogenic Factors in Systemic Lupus Erythematosus and Their Clinical Significance;BioMed Research International;2014

5. Patients with Ankylosing Spondylitis and Low Disease Activity because of Anti-TNF-Alpha Therapy Have Higher TRAIL Levels Than Controls: A Potential Compensatory Effect;Mediators of Inflammation;2014